Compass Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-635
| Closed | -$51.5K | – | 423 |
|
|
2025
Q1 | $51.5K | Buy |
635
+200
| +46% | +$16.2K | 0.01% | 243 |
|
|
2024
Q4 | $39.2K | Hold |
435
| – | – | 0.01% | 266 |
|
|
2024
Q3 | $43K | Hold |
435
| – | – | 0.01% | 266 |
|
|
2024
Q2 | $40.3K | Hold |
435
| – | – | 0.01% | 273 |
|
|
2024
Q1 | $41.3K | Hold |
435
| – | – | 0.01% | 266 |
|
|
2023
Q4 | $38.8K | Buy |
435
+30
| +7% | +$2.68K | 0.01% | 265 |
|
|
2023
Q3 | $29.6K | Hold |
405
| – | – | 0.01% | 282 |
|
|
2023
Q2 | $33.7K | Hold |
405
| – | – | 0.01% | 282 |
|
|
2023
Q1 | $30.9K | Hold |
405
| – | – | 0.01% | 291 |
|
|
2022
Q4 | $33.6K | Buy |
+405
| New | +$33.6K | 0.01% | 272 |
|